The Valley Desk

NCT04844749 · Interventional trial

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

Overall registry status Terminated

Phase 3

Conditions Androgen Resistant Prostatic Cancer, Metastatic Castration-resistant Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov